Ngenla 60 mg/ 1.2 ml, Injektionslösung im Fertigpen
7680682650026
CH-68265
Injektionslösung im Fertigpen
Associated product:
NGENLA sol inj 60 mg/1.2ml stylo pré
1 / 2
google
Article details
- Package size
- 1.2
- Selling units
- 1
- Measure
- ml
- Galenic form
- Injektionslösung im Fertigpen
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 790.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2022
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 68265
- Drug name
- Ngenla, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- H01AC08
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 09/09/2022
- Authorization expiration date
- 08/09/2027
- IT Number
- 07.03.1.
- Domain
- Human medicine
Package details
- Description (FR)
- NGENLA sol inj 60 mg/1.2ml stylo pré
- Description (DE)
- NGENLA Inj Lös 60 mg/1.2ml Fertpen
- Market launch
- 09/09/2022
- Narcotic (BTM)
- No
Other package sizes (1)
NGENLA sol inj 24 mg/1.2ml stylo pré
1.2 ML
GTIN: 7680682650019